Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Bray

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of the American Academy of Dermatology|May 13, 2014
Update on primary mucosal melanomaJoselin D Tacastacas, Julie Bray, Yoon K Cohen, et al.
The Oncologist|December 30, 2025
EXTRA-PC: A phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancerAlbert Jang, Peggy Fowler, Kathryn Helminiak, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of the American Academy of Dermatology|May 13, 2014
Update on primary mucosal melanomaJoselin D Tacastacas, Julie Bray, Yoon K Cohen, et al.
The Oncologist|December 30, 2025
EXTRA-PC: A phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancerAlbert Jang, Peggy Fowler, Kathryn Helminiak, et al.
Pageof 1